Michael C. Quirk

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Brandon Marsh, attorney in fact for Michael C. Quirk
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael C. Quirk:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Scientific Officer and Interim Head of R&D Common Stock 0 $0 $9.27 31 Jul 2025 Direct
Sage Therapeutics, Inc. Chief Scientific Officer and Interim Head of R&D S 4K 01 Apr 2025 Direct
Sage Therapeutics, Inc. Chief Scientific Officer and Interim Head of R&D Stock Option (Right to Buy) 0 31 Jul 2025 Direct

Insider Reports Filed by Michael C. Quirk

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SAGE Sage Therapeutics, Inc. 31 Jul 2025 4 $0 4 Chief Scientific Officer and Interim Head of R&D 31 Jul 2025, 12:04
SAGE Sage Therapeutics, Inc. 24 Jun 2025 1 -$1.04K 4 Chief Scientific Officer and Interim Head of R&D 26 Jun 2025, 16:02
SAGE Sage Therapeutics, Inc. 10 Apr 2025 4 -$5.09K 4 Chief Scientific Officer and Interim Head of R&D 11 Apr 2025, 16:09
SAGE Sage Therapeutics, Inc. 01 Apr 2025 2 $0 4 Chief Scientific Officer and Interim Head of R&D 02 Apr 2025, 16:06
SAGE Sage Therapeutics, Inc. 01 Apr 2025 0 $0 3 Chief Scientific Officer and Interim Head of R&D 02 Apr 2025, 16:06